Trupanion, Inc. (NASDAQ:TRUP) Given Consensus Rating of “Hold” by Brokerages

Trupanion, Inc. (NASDAQ:TRUP) has been given an average recommendation of “Hold” by the six analysts that are covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $39.20.

Several equities analysts recently commented on TRUP shares. Atlantic Securities set a $42.00 price target on shares of Trupanion in a research note on Wednesday, July 15th. Stifel Nicolaus lifted their price objective on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Piper Sandler downgraded shares of Trupanion from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. Weiss Ratings upgraded shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, August 26th. Finally, Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 978 shares of Trupanion stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the transaction, the chief executive officer directly owned 175,401 shares of the company’s stock, valued at $5,095,399.05. The trade was a 0.55% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Fawwad Qureshi sold 6,111 shares of the company’s stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total transaction of $183,391.11. Following the sale, the chief financial officer directly owned 4,230 shares of the company’s stock, valued at $126,942.30. This represents a 59.09% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 12,046 shares of company stock worth $356,210. Company insiders own 5.58% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Thrivent Financial for Lutherans grew its holdings in shares of Trupanion by 1.1% during the second quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock worth $1,376,000 after purchasing an additional 282 shares during the last quarter. EP Wealth Advisors LLC raised its holdings in Trupanion by 2.9% in the 2nd quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock valued at $571,000 after buying an additional 292 shares during the last quarter. Illinois Municipal Retirement Fund raised its holdings in Trupanion by 2.3% in the 1st quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock valued at $456,000 after buying an additional 406 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Trupanion by 2.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider’s stock valued at $1,258,000 after buying an additional 725 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Trupanion by 3.8% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after buying an additional 737 shares during the period.

Trupanion Stock Performance

TRUP opened at $28.79 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The business has a fifty day simple moving average of $27.39 and a 200 day simple moving average of $25.87. Trupanion has a 1 year low of $21.16 and a 1 year high of $46.98. The company has a market capitalization of $1.26 billion, a PE ratio of 54.32, a price-to-earnings-growth ratio of 1.91 and a beta of 1.45.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm had revenue of $392.93 million for the quarter, compared to analysts’ expectations of $389.72 million. During the same quarter last year, the business earned $0.22 EPS. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. Research analysts expect that Trupanion will post 0.63 EPS for the current year.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.